VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > LUBE

<< Previous

Bullboard Posts

Next >>

Comment by Enoughon Nov 04, 2021 1:20pm

148 Views

Post# 34087558

RE:RE:RE:RE:LUBE

Abouttime1 wrote: When the pp made our shares diluted, some realized they were deluded, as the price action was de-lube-ed. Triple d 40 required.

That's a good point.

So we have a lube that is diluted

So we need a thicker lube.

Maybe the lube could be more substantial as well-instead of flimsy new releases with freebies, and no freaking sales

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario